Do inositol supplements enhance phosphatidylinositol supply and thus support endoplasmic reticulum function?

Area of Science:

• Biochemistry
• Cell Biology
• Metabolic Disorders

Background:

• Myoinositol (Ins) is crucial for cell membranes, particularly phosphatidylinositol (PtdIns).
• Dietary Ins sufficiency was assumed, but new evidence links increased intake to improved outcomes in various disorders.
• Existing explanations for Ins benefits are incomplete, lacking selectivity for certain conditions.

Purpose of the Study:

• To explain the benefits of myoinositol (Ins) supplementation in conditions with insulin resistance, non-alcoholic fatty liver disease, and endoplasmic reticulum (ER) stress.
• To propose that Ins benefits stem from correcting a deficiency in phosphatidylinositol (PtdIns) synthesis.
• To reframe Ins deficiency as a failure to adapt to ER stress.

Main Methods:

• Review and reinterpretation of existing scientific literature on myoinositol (Ins) and related metabolic disorders.
• Analysis of the role of phosphatidylinositol (PtdIns) in endoplasmic reticulum (ER) membrane synthesis and stress response.
• Hypothesizing the mechanism of Ins supplementation in ER-stressed cells.

Main Results:

• Conditions like PCOS, gestational diabetes, and metabolic syndrome may benefit from increased Ins intake.
• Ins supplementation likely corrects a deficit in phosphatidylinositol (PtdIns), essential for ER membrane expansion.
• Increased Ins supply supports stressed cells in synthesizing PtdIns, enhancing ER function and adaptation.

Conclusions:

• Dietary myoinositol (Ins) supplementation is beneficial for disorders characterized by insulin resistance and ER stress.
• The primary mechanism involves restoring phosphatidylinositol (PtdIns) levels for adequate ER membrane synthesis and function.
• This approach corrects a cellular Ins reserve deficiency, improving ER stress adaptation.